Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Recruiting now · Phase 1/Phase 2

Conditions studied: Tumor, Cardiovascular Diseases, Pulmonary Fibrosis, Rheumatic Immune Diseases Involving Large Blood Vessels, Hypertrophic Cardiomyopathy (HCM), Other Hypoxic and Fibroblast Activated Diseases

In brief

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.

Key facts

Study ID

NCT07464132

Run by

Peking Union Medical College Hospital

People needed

30

Starts

2025-12-17

Expected to finish

2027-06-17

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 1: 18-85 years old
• 2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis
• 3: Ability to understand and sign informed consent forms
• 4: Expected survival period exceeding 6 months and able to receive follow-up
• 5: Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc

You may not qualify if…

• 1: Pregnant or lactating women
• 2: Patients allergic to research drug ingredients
• 3: Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 μ mol/L)
• 4: Patients who participate in other clinical trials and interfere with the results of this study
• 5: Patients with severe illness who cannot cooperate with the examination

Where it is running

• Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.